1. Du, Xue, Shao, Yun, Qin, Hai-Feng, Tai, Yan-Hong, Gao, Hong-Jun. 2018. ALK-rearrangement in non-small-cell lung cancer (NSCLC). In Thoracic cancer, 9, 423-430. doi:10.1111/1759-7714.12613. https://pubmed.ncbi.nlm.nih.gov/29488330/
2. Siblini, Laura, Schott, Roland, Trensz, Philippe, Pencreach, Erwan, Bender, Laura. 2023. Primary resistance to ALK inhibitors in KLC1/ALK-rearranged pleural metastatic lung adenocarcinoma: a case report. In Translational lung cancer research, 12, 2342-2346. doi:10.21037/tlcr-23-482. https://pubmed.ncbi.nlm.nih.gov/38090529/
3. Chen, Xu-Qiao, Das, Utpal, Park, Gooho, Mobley, William C. 2021. Normal levels of KIF5 but reduced KLC1 levels in both Alzheimer disease and Alzheimer disease in Down syndrome: evidence suggesting defects in anterograde transport. In Alzheimer's research & therapy, 13, 59. doi:10.1186/s13195-021-00796-6. https://pubmed.ncbi.nlm.nih.gov/33691783/
4. Lou, Shu, Zhu, Guirong, Xing, Changyue, Du, Mulong, Pan, Yongchu. 2024. Transcriptome-wide association identifies KLC1 as a regulator of mitophagy in non-syndromic cleft lip with or without palate. In iMeta, 3, e262. doi:10.1002/imt2.262. https://pubmed.ncbi.nlm.nih.gov/39742305/
5. Wang, Peng, Xiao, Pei, Ye, Yingnan, She, Chunhua, Yu, Jinpu. . Rapid response of brain metastasis to crizotinib in a patient with KLC1-ALK fusion and MET gene amplification positive non-small cell lung cancer: a case report. In Cancer biology & medicine, 14, 183-186. doi:10.20892/j.issn.2095-3941.2017.0017. https://pubmed.ncbi.nlm.nih.gov/28607809/
智鼠故事 
